查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太下一代介入性心臟病學市場：按產品類型、適應症類型、最終用戶和國家進行分析和預測（2025-2035 年）
市場調查報告書
商品編碼
1800749

亞太下一代介入性心臟病學市場：按產品類型、適應症類型、最終用戶和國家進行分析和預測（2025-2035 年）

Asia-Pacific Next-Generation Intervention Cardiology Market: Focus on Product Type, Indication Type, End User, and Country - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 85 Pages | 商品交期: 1-5個工作天內

價格

亞太地區下一代介入性心臟病學市場規模預計將從 2024 年的 53.409 億美元增至 2035 年的 130.537 億美元，預測期內的複合年成長率為 8.46%。

新一代介入性心臟病學正在改變亞太地區的心臟護理，該技術採用先進的微創精準引導手術來治療結構性心臟疾病、冠狀動脈疾病和瓣膜疾病。傳統的開胸心臟手術顯然正在被更安全、更適合患者的導管手術所取代。為了提高安全性、準確性和手術效率，亞太地區的醫療保健專業人員擴大利用機器人技術、人工智慧驅動的影像技術和尖端醫療設備技術。這些進步與該地區的醫療重點一致：擴大先進醫療服務的機會、降低治療成本、並應對與快速老化和人口成長相關的心血管疾病盛行率上升的問題。這些進步也正在改善臨床療效並縮短復原時間。

主要市場統計數據
預測期 2025-2035
2025年評估 56.918億美元
2035年預測 130.537億美元
複合年成長率 8.46%

由於心血管疾病發病率的上升以及對微創手術的需求不斷成長，該地區的新一代介入性心臟病學市場正在顯著擴張。韓國、中國和日本等國人口老化速度加快，加上印度和東南亞地區生活方式相關心臟疾病風險的上升，導致該地區廣泛使用先進的導管介入手術來取代傳統的開胸心臟手術。

該地區的新一代介入性心臟病學市場正在利用機器人技術、人工智慧增強成像和尖端設備技術來提高準確性、減少併發症並加快康復速度。該地區的醫療保健系統正擴大採用藥物釋放型支架、生物可吸收支架、經導管主動脈瓣置換術(TAVR) 和經導管二尖瓣瓣膜修復(TMVR) 等技術。此外，門診手術中心、混合導管實驗室和數位醫療整合的擴展正在擴大患者獲得先進治療的機會。

世界各國政府正積極推動醫療保健現代化，包括資助計畫、優惠的報銷制度和基礎設施投資。目前，大規模的醫院擴建正在進行中，尤其是在中國和印度。儘管醫療保健可近性差異和成本壓力等挑戰依然存在，但持續的研發投入、全球醫療設備公司與本地公司之間的夥伴關係以及患者意識的不斷提升，正使該地區成為下一代介入性心臟病學快速成長的市場。

市場區隔

細分 1：按產品類型

  • 機器人技術
    • 機器人輔助經皮冠狀動脈介入治療（R-PCI）
    • 機器人輔助冠狀動脈繞道手術手術（RA-CABG）
    • 機器人輔助二尖瓣置換術（RMVR）
    • 機器人輔助主動脈瓣置換術
  • 非機器人
    • IVUS
    • OCT
    • 其他
      • 支架
      • 導管
      • 導管導引線
      • PTCA球囊擴張術
      • 其他

細分2：依適應症類型

  • 結構性心臟疾病
  • 冠狀動脈疾病
  • 心臟瓣膜疾病
  • 周邊動脈疾病
  • 先天性心臟疾病

細分 3：按最終用戶

  • 醫院和診所
  • 心臟中心
  • 門診手術中心

細分4：按地區

  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 澳洲
    • 韓國
    • 其他

本報告調查了亞太地區的下一代介入性心臟病學市場，並總結了關鍵趨勢、市場影響因素分析、法律制度、技術和管道趨勢、市場規模趨勢和預測、各個細分市場、地區/主要國家的詳細分析、競爭格局和主要企業的概況。

目錄

執行摘要

範圍和定義

第1章：下一代介入性心臟病學市場：產業展望

  • 競爭格局
    • 商業策略
  • 下一代介入性心臟病學市場：診斷與管理
  • 冠狀動脈介入治療的進展
  • 冠狀動脈介入的未來方向和新興技術
  • 下一代介入性心臟病學市場中的研發線產品
  • 監管狀況
    • 亞太地區

第2章 市場動態

  • 趨勢
    • 下一代介入性心臟病學市場趨勢
  • 市場動態
    • 趨勢、促進因素、挑戰和機會：評估當前和未來的影響
    • 市場促進因素
    • 市場限制
    • 市場機會
    • 市場挑戰

第3章 下一代介入性心臟病學市場（按地區）

  • 區域摘要
  • 亞太地區
    • 區域概況
    • 市場成長動力
    • 市場問題
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他

第4章 競爭格局與公司概況

  • 公司簡介
    • Terumo Corporation

第5章調查方法

Product Code: BHL3210SS

This report can be delivered in 2 working days.

Introduction to Asia-Pacific Next-Generation Intervention Cardiology Market

The Asia-Pacific next-generation intervention cardiology market is projected to reach $13,053.7 million by 2035 from $5,340.9 million in 2024, growing at a CAGR of 8.46% during the forecast period 2025-2035. Asian-Pacific (APAC) cardiac care is being revolutionized by next-generation interventional cardiology, which uses advanced, minimally invasive, precision-guided procedures to treat structural heart defects, coronary artery disease, and valvular illnesses. Traditional open-heart surgeries are clearly giving way to safer, more patient-specific catheter-based procedures around the region. In order to improve safety, accuracy, and procedural efficiency, healthcare professionals in Asia-Pacific are increasingly utilizing robotics, AI-driven imaging, and cutting-edge gadget technologies. The region's healthcare priorities of increasing access to cutting-edge therapies, lowering treatment costs, and addressing the rising prevalence of cardiovascular diseases in rapidly aging and growing populations are all in line with this advancement, which also improves clinical outcomes and speeds up recovery times.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$5,691.8 Million
2035 Forecast$13,053.7 Million
CAGR8.46%

Market Introduction

The market for next-generation interventional cardiology in Asia-Pacific (APAC) is expanding significantly due to the rising prevalence of cardiovascular illnesses and the growing need for minimally invasive procedures. Advanced catheter-based procedures are becoming more popular in the region as alternatives to traditional open-heart surgeries because to the rapidly aging populations in nations like South Korea, China, and Japan as well as the rising lifestyle-related cardiac risks in India and Southeast Asia.

Robotics, AI-enhanced imaging, and cutting-edge device technologies are all used in APAC's next-generation interventional cardiology to provide increased precision, fewer problems, and quicker recovery. The region's healthcare systems are increasingly implementing technologies including drug-eluting stents, bioresorbable scaffolds, transcatheter aortic valve replacement (TAVR), and transcatheter mitral valve repair (TMVR). Furthermore, patient access to these cutting-edge treatments is being increased by the rise of ambulatory surgery centers, hybrid cath laboratories, and digital health integration.

With funding programs, advantageous reimbursement practices, and infrastructure expenditures, governments throughout Asia-Pacific are aggressively promoting healthcare modernization. This is especially true in China and India, where massive hospital expansions are currently taking place. While challenges such as disparities in healthcare access and cost pressures persist, continuous R&D efforts, partnerships between global medtech firms and local players, and increasing patient awareness are positioning APAC as a fast-emerging market for next-generation interventional cardiology.

Market Segmentation:

Segmentation 1: By Product Type

  • Robotics
    • Robotic-Assisted Percutaneous Coronary Intervention (R-PCI)
    • Robotic-Assisted Coronary Artery Bypass Grafting (RA-CABG)
    • Robotic Assisted Mitral Valve-Replacement (RMVR)
    • Robotic Assisted Aortic Valve Replacement
  • Non-Robotics
    • IVUS
    • OCT
    • Other Interventions
      • Stents
      • Catheters
      • Guidewires
      • PTCA Balloons
      • Others

Segmentation 2: By Indication Type

  • Structural Heart Disease
  • Coronary Heart Diseases
  • Valvular Heart Diseases
  • Peripheral Artery Diseases
  • Congenital Heart Diseases

Segmentation 3: By End User

  • Hospitals and Clinics
  • Cardiac Centers
  • Ambulatory Surgical Centers

Segmentation 4: By Region

  • Asia-Pacific
    • Japan
    • India
    • China
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific

APAC Next-Generation Intervention Cardiology Market Trends, Drivers and Challenges

Trends

  • Rapid shift from open-heart surgery to minimally invasive catheter-based procedures.
  • Growing adoption of robotics, AI-enhanced imaging, and 3D navigation in interventional cardiology.
  • Rising uptake of TAVR (Transcatheter Aortic Valve Replacement), TMVR (Transcatheter Mitral Valve Repair), bioresorbable scaffolds, and drug-coated balloons.
  • Expansion of hybrid cath labs and ambulatory surgical centers across urban and semi-urban regions.
  • Integration of digital health, telecardiology, and remote monitoring into cardiovascular care.
  • Increasing cross-border collaborations between global medtech firms and regional healthcare providers.

Drivers

  • High prevalence of cardiovascular diseases due to aging populations and lifestyle factors (e.g., diabetes, obesity, hypertension).
  • Rising healthcare investments in China, India, Japan, and South Korea to expand advanced cardiology services.
  • Strong push for healthcare modernization through government-funded programs and infrastructure expansion.
  • Growing patient awareness and demand for safer, faster, and less invasive treatment options.
  • Increasing medical tourism in APAC (particularly India, Thailand, and Singapore) for advanced cardiac procedures.

Challenges

  • Healthcare access disparities between urban and rural areas across APAC.
  • High procedure and device costs limiting widespread adoption in developing economies.
  • Complex regulatory environments and approval delays for next-gen medical devices.
  • Shortage of skilled interventional cardiologists and trained staff in emerging markets.
  • Reimbursement gaps and limited insurance coverage for advanced procedures in several countries.

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in APAC next-generation intervention cardiology, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses in APAC next-generation intervention cardiology and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines specific to APAC next-generation intervention cardiology, ensuring organizations stay compliant and accelerate market entry for new next-generation intervention cardiology

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Table of Contents

Executive Summary

Scope and Definition

1 Next-Generation Intervention Cardiology Market: Industry Outlook

  • 1.1 Competitive Landscape
    • 1.1.1 Business Strategies
      • 1.1.1.1 Product Developments in Next-Generation Intervention Cardiology Market
  • 1.2 Next-Generation Intervention Cardiology Market: Diagnosis and Management
  • 1.3 Advancements in Coronary Intervention
  • 1.4 Future Direction and Emerging Technologies in Coronary Interventions
  • 1.5 Pipeline Products in the Next-Generation Intervention Cardiology Market
  • 1.6 Regulatory Landscape
    • 1.6.1 Asia-Pacific
      • 1.6.1.1 Japan
      • 1.6.1.2 China
      • 1.6.1.3 India

2 Market Dynamics

  • 2.1 Trends
    • 2.1.1 Trends in the Next-Generation Intervention Cardiology Market
      • 2.1.1.1 Shift towards Minimally Invasive and Percutaneous Procedures Transforming Treatment Paradigms
      • 2.1.1.2 Integration of AI-Predictive Intelligence in Intervention Cardiology
        • 2.1.1.2.1 AI in Imaging, Lesion Assessment, and Diagnostics
  • 2.2 Market Dynamics
    • 2.2.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
    • 2.2.2 Market Drivers
      • 2.2.2.1 Rising Elderly Population, Driving Demand for Advanced Cardiac Interventions
        • 2.2.2.1.1 Cardiovascular Disease Burden in the Elderly
      • 2.2.2.2 Emergence of Robotic-Assisted Interventions- Enhancing Procedural Accuracy and Operator Control
    • 2.2.3 Market Restraints
      • 2.2.3.1 High Procedural Cost and Infrastructure Burden Limiting Broad Adoption
      • 2.2.3.2 Regulatory Complexity and Prolonged Approval Timelines Hindering Innovation
        • 2.2.3.2.1 Lengthy Approval Pathways for High-Risk Devices
        • 2.2.3.2.2 Lack of Harmonization across Geographies
        • 2.2.3.2.3 Regulatory Gaps for AI and Software-Driven Devices
    • 2.2.4 Market Opportunities
      • 2.2.4.1 Stent and Balloon Innovation Unlocking Next-Generation Use Cases
        • 2.2.4.1.1 Advancements in Drug-Coated Balloon Technologies
      • 2.2.4.2 Remote and Robotic-Enabled Expansion into Emerging Markets
        • 2.2.4.2.1 Bridging Access Gaps through Remote Robotics
    • 2.2.5 Market Challenges
      • 2.2.5.1 Data Standardization and Clinical Validation Gaps in AI-Driven Cardiology
      • 2.2.5.2 Safety and Clinical Validation Barriers for Next-Generation Vascular Implants

3 Next-Generation Intervention Cardiology Market (Region), Value ($million), 2024-2035

  • 3.1 Regional Summary
  • 3.2 Asia-Pacific
    • 3.2.1 Regional Overview
    • 3.2.2 Driving Factors for Market Growth
    • 3.2.3 Factors Challenging the Market
    • 3.2.4 Japan
    • 3.2.5 China
    • 3.2.6 India
    • 3.2.7 Australia
    • 3.2.8 South Korea
    • 3.2.9 Rest-of-Asia-Pacific

4 Competitive Landscape and Company Profiles

  • 4.1 Company Profiles
    • 4.1.1 Terumo Corporation
      • 4.1.1.1 Overview
      • 4.1.1.2 Top Products/Product Portfolio
      • 4.1.1.3 Top Competitors
      • 4.1.1.4 Target Customers
      • 4.1.1.5 Strategic Positioning and Market Impact
      • 4.1.1.6 Analyst View
      • 4.1.1.7 Pipeline and Research Initiatives

5 Research Methodology

  • 5.1 Data Sources
    • 5.1.1 Primary Data Sources
    • 5.1.2 Secondary Data Sources
    • 5.1.3 Inclusion and Exclusion
    • 5.1.4 Data Triangulation
  • 5.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Next-Generation Intervention Cardiology Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Asia-Pacific Next-Generation Intervention Cardiology Market Snapshot
  • Figure 3: Asia-Pacific Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024, 2028, and 2035
  • Figure 4: Asia-Pacific Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024, 2028, and 2035
  • Figure 5: Asia-Pacific Next-Generation Intervention Cardiology Market (by End User), $Million, 2024, 2028, and 2035
  • Figure 6: Cardiovascular Disease Statistics
  • Figure 7: Inclusion and Exclusion Criteria for Next-Generation Intervention Cardiology Market
  • Figure 8: Data Triangulation
  • Figure 9: Top-Down and Bottom-Up Approach
  • Figure 10: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Pipeline Products in Next-Generation Intervention Cardiology Market
  • Table 3: Next-Generation Intervention Cardiology Market (by Region), $Million, 2024-2035
  • Table 4: Asia-Pacific Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 5: Asia-Pacific Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 6: Asia-Pacific Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 7: Asia-Pacific Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 8: Asia-Pacific Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 9: Asia-Pacific Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 10: Asia-Pacific Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 11: Japan Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 12: Japan Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 13: Japan Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 14: Japan Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 15: Japan Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 16: Japan Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 17: Japan Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 18: China Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 19: China Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 20: China Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 21: China Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 22: China Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 23: China Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 24: China Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 25: India Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 26: India Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 27: India Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 28: India Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 29: India Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 30: India Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 31: India Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 32: Australia Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 33: Australia Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 34: Australia Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 35: Australia Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 36: Australia Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 37: Australia Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 38: Australia Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 39: South Korea Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 40: South Korea Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 41: South Korea Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 42: South Korea Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 43: South Korea Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 44: South Korea Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 45: South Korea Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 46: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 47: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 48: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 49: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 50: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 51: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 52: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035